These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 17368862)
21. Tandospirone activates neuroendocrine and ERK (MAP kinase) signaling pathways specifically through 5-HT1A receptor mechanisms in vivo. Sullivan NR; Crane JW; Damjanoska KJ; Carrasco GA; D'Souza DN; Garcia F; Van de Kar LD Naunyn Schmiedebergs Arch Pharmacol; 2005 Jan; 371(1):18-26. PubMed ID: 15655673 [TBL] [Abstract][Full Text] [Related]
22. Effects of acute citalopram on the expression of conditioned freezing in naive versus chronic citalopram-treated rats. Hashimoto S; Inoue T; Muraki I; Koyama T Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):113-7. PubMed ID: 19010374 [TBL] [Abstract][Full Text] [Related]
23. 5-HT1A agonists disrupt memory of fear conditioning in mice. Quartermain D; Clemente J; Shemer A Biol Psychiatry; 1993 Feb; 33(4):247-54. PubMed ID: 8471677 [TBL] [Abstract][Full Text] [Related]
24. Target brain sites of the anxiolytic effect of citalopram, a selective serotonin reuptake inhibitor. Izumi T; Inoue T; Kitaichi Y; Nakagawa S; Koyama T Eur J Pharmacol; 2006 Mar; 534(1-3):129-32. PubMed ID: 16494863 [TBL] [Abstract][Full Text] [Related]
25. [First death case of serotonin syndrome in Japan induced by fluvoxamine and tandospirone]. Kawano T; Kosuge T; Takagi S; Shimoyama A; Harunari N; Tahara Y; Suzuki N Chudoku Kenkyu; 2011 Dec; 24(4):305-10. PubMed ID: 22338341 [TBL] [Abstract][Full Text] [Related]
26. Tandospirone potentiates the fluoxetine-induced increases in extracellular dopamine via 5-HT(1A) receptors in the rat medial frontal cortex. Yoshino T; Nisijima K; Katoh S; Yui K; Nakamura M Neurochem Int; 2002 Apr; 40(4):355-60. PubMed ID: 11792466 [TBL] [Abstract][Full Text] [Related]
27. Effects of tandospirone, a 5-HT1A agonistic anxiolytic agent, on haloperidol-induced catalepsy and forebrain Fos expression in mice. Ohno Y; Shimizu S; Imaki J J Pharmacol Sci; 2009 Apr; 109(4):593-9. PubMed ID: 19352073 [TBL] [Abstract][Full Text] [Related]
28. Chronic treatment with tandospirone, a serotonin 1A receptor partial agonist, inhibits psychosocial stress-induced changes in hippocampal neurogenesis and behavior. Murata Y; Yanagihara Y; Mori M; Mine K; Enjoji M J Affect Disord; 2015 Jul; 180():1-9. PubMed ID: 25879718 [TBL] [Abstract][Full Text] [Related]
29. Effects of tandospirone augmentation in major depressive disorder patients with high anxiety: A multicenter, randomized, parallel-controlled, open-label study. Lin J; Su Y; Wang C; Yang F; Xu Y; Yuan Y; Yuan Y; Wang X; Yu X; Si T J Psychiatr Res; 2018 Apr; 99():104-110. PubMed ID: 29433063 [TBL] [Abstract][Full Text] [Related]
30. Tandospirone suppresses impulsive action by possible blockade of the 5-HT1A receptor. Ohmura Y; Kumamoto H; Tsutsui-Kimura I; Minami M; Izumi T; Yoshida T; Yoshioka M J Pharmacol Sci; 2013; 122(2):84-92. PubMed ID: 23707971 [TBL] [Abstract][Full Text] [Related]
31. Effects of conditioned fear stress on serotonin neurotransmission and freezing behavior in rats. Hashimoto S; Inoue T; Koyama T Eur J Pharmacol; 1999 Jul; 378(1):23-30. PubMed ID: 10478561 [TBL] [Abstract][Full Text] [Related]
32. Serotonergic activation reduces defensive freezing in the conditioned fear paradigm. Inoue T; Tsuchiya K; Koyama T Pharmacol Biochem Behav; 1996 Apr; 53(4):825-31. PubMed ID: 8801584 [TBL] [Abstract][Full Text] [Related]
33. Selective serotonin reuptake inhibitor reduces conditioned fear through its effect in the amygdala. Inoue T; Li XB; Abekawa T; Kitaichi Y; Izumi T; Nakagawa S; Koyama T Eur J Pharmacol; 2004 Aug; 497(3):311-6. PubMed ID: 15336949 [TBL] [Abstract][Full Text] [Related]
35. Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats. Mochizuki D; Tsujita R; Yamada S; Kawasaki K; Otsuka Y; Hashimoto S; Hattori T; Kitamura Y; Miki N Psychopharmacology (Berl); 2002 Jul; 162(3):323-32. PubMed ID: 12122491 [TBL] [Abstract][Full Text] [Related]
36. Escitalopram attenuates fear stress-induced increase in amygdalar dopamine following methamphetamine-induced sensitisation: Implications of fine-tuning action of selective serotonin reuptake inhibitors on emotional processing. Muraoka H; Oshibuchi H; Kawano M; Kawano T; Tsutsumi T; Yamada M; Ishigooka J; Nishimura K; Inada K Eur J Pharmacol; 2018 Sep; 834():1-9. PubMed ID: 29981749 [TBL] [Abstract][Full Text] [Related]
37. Tandospirone stimulates prolactin secretion in the rat by an action at serotonin-1A receptors. Mulroney SE; Skudlarek C; Shemer A; Lumpkin MD; Kellar KJ J Pharmacol Exp Ther; 1994 Feb; 268(2):862-7. PubMed ID: 8113999 [TBL] [Abstract][Full Text] [Related]
38. Different effects of anxiolytic agents, diazepam and 5-HT(1A) agonist tandospirone, on hippocampal long-term potentiation in vivo. Mori K; Togashi H; Kojima T; Matsumoto M; Ohashi S; Ueno K; Yoshioka M Pharmacol Biochem Behav; 2001; 69(3-4):367-72. PubMed ID: 11509193 [TBL] [Abstract][Full Text] [Related]
39. Effect of paroxetine on enhanced contextual fear induced by single prolonged stress in rats. Takahashi T; Morinobu S; Iwamoto Y; Yamawaki S Psychopharmacology (Berl); 2006 Dec; 189(2):165-73. PubMed ID: 17031709 [TBL] [Abstract][Full Text] [Related]
40. Acute and chronic effects of selective serotonin reuptake inhibitor treatment on fear conditioning: implications for underlying fear circuits. Burghardt NS; Bauer EP Neuroscience; 2013 Sep; 247():253-72. PubMed ID: 23732229 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]